Antibiotic Prophylaxis for Genitourinary Procedures in Patients with Artificial Joint Replacement and Artificial Heart Valves

Authors

Briana Goddard, Department of Urology, George Washington University Hospital, 2150 Pennsylvania Avenue Northwest Suite 3-417, Washington, DC 20037, USA. Electronic address: brianalgoddard@gmail.com.
Daniel Stein, Department of Urology, George Washington University Hospital, 2150 Pennsylvania Avenue Northwest Suite 3-417, Washington, DC 20037, USA.

Document Type

Journal Article

Publication Date

11-1-2024

Journal

The Urologic clinics of North America

Volume

51

Issue

4

DOI

10.1016/j.ucl.2024.06.002

Keywords

Antibiotic prophylaxis; Genitourinary procedure; Prosthetic joint infection; Prosthetic valve endocarditis

Abstract

Prosthetic joint infection (PJI) and prosthetic valve endocarditis (PVE) are uncommon but serious complications. According to current best practice statements, prior to a genitourinary procedure, patients with prosthetic joints should receive antibiotic prophylaxis if they are within 2 years of arthroplasty, if they are high risk for infection due to their individual comorbidities, or if the procedure poses a high risk for bacteremia. Patients with prosthetic valves should not receive antibiotic prophylaxis for the sole purpose of prevention of endocarditis. Enterococcus species are the uropathogens most often associated with PJI and PVE. Antibiotic selection should take into account local resistance patterns.

APA Citation

Goddard, Briana and Stein, Daniel, "Antibiotic Prophylaxis for Genitourinary Procedures in Patients with Artificial Joint Replacement and Artificial Heart Valves" (2024). GW Authored Works. Paper 6074.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6074

Department

Urology